| Schedule Of Other Financial Instruments In Carrying Values And Fair Values |
Our other financial instruments had the following carrying values and fair values as of the dates shown (dollars in thousands): | | | | | | | | | | | | | | | | | | | | | | December 31, 2016 | | December 31, 2015 | | Level | | Carrying Value | | Fair Value | | Carrying Value | | Fair Value | Non-recourse debt (a) (b) | 3 | | $ | 2,022,250 |
| | $ | 2,053,353 |
| | $ | 1,881,774 |
| | $ | 1,937,459 |
| Loans receivable (b) | 3 | | 31,500 |
| | 31,500 |
| | 44,044 |
| | 44,044 |
| CMBS (c) | 3 | | 4,027 |
| | 7,470 |
| | 2,765 |
| | 8,739 |
|
___________ | | (a) | In accordance with ASU 2015-03, we reclassified deferred financing costs from Other assets, net to Non-recourse debt, net and Senior Credit Facility, net as of December 31, 2015, for the amount of $12.8 million (Note 2). The carrying value of Non-recourse debt, net includes unamortized deferred financing costs of $9.3 million and $12.5 million at December 31, 2016 and 2015, respectively. |
| | (b) | We determined the estimated fair value of these financial instruments using a discounted cash flow model that estimates the present value of the future loan payments by discounting such payments at current estimated market interest rates. The estimated market interest rates take into account interest rate risk and the value of the underlying collateral, which includes quality of the collateral, the credit quality of the tenant/obligor, and the time until maturity. |
| | (c) | At December 31, 2016 and 2015, we had three separate tranches of CMBS investments, which are scheduled to mature between November 2017 and February 2018. The carrying value of our CMBS is inclusive of impairment charges for the years ended December 31, 2016 and 2015, as well as accretion related to the estimated cash flows expected to be received. |
|
| Schedule Of Fair Value Impairment Charges Using Unobservable Inputs Nonrecurring Basis |
The following table presents information about the assets for which we recorded an impairment charge that was measured at fair value on a non-recurring basis (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, 2016 | | Year Ended December 31, 2015 | | Year Ended December 31, 2014 | | Fair Value Measurements | | Total Impairment Charges | | Fair Value Measurements | | Total Impairment Charges | | Fair Value Measurements | | Total Impairment Charges | Impairment Charges | |
| | |
| | |
| | |
| | |
| | |
| Real estate | $ | 14,850 |
| | $ | 29,183 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| CMBS | 400 |
| | 523 |
| | 1,478 |
| | 1,023 |
| | 1,808 |
| | 570 |
| | | | 29,706 |
| | | | 1,023 |
| | | | 570 |
| Equity investments in real estate | 12,528 |
| | 1,919 |
| | — |
| | — |
| | 7,662 |
| | 766 |
| | | | $ | 31,625 |
| | | | $ | 1,023 |
| | | | $ | 1,336 |
|
|